Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
chronic kidney disease
.
Show all posts
Showing posts with label
chronic kidney disease
.
Show all posts
Tuesday, February 27, 2024
FDA Approves Jesduvroq (daprodustat) for Anemia Caused by Chronic Kidney Disease for Adults on Dialysis
›
GSK plc (LSE/NYSE: GSK) announced the US Food and Drug Administration (FDA) approval of Jesduvroq (daprodustat), an oral hypoxia-inducible...
Friday, February 10, 2017
FDA Approves Rayaldee (calcifediol) to Treat Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease
›
OPKO Health, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Rayaldee (calcifediol) extended release capsul...
Monday, August 13, 2012
Savient announces results from KRYSTEXXA Phase III trials on gout-related kidney disease
›
Post-hoc analysis evaluated more than 200 patients with CKD stages one through four (n=34, 74, 80, 23, respectively) who were randomiz...
›
Home
View web version